Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Biogen Inc
Recent news which mentions Biogen Inc
< Previous
1
2
3
Next >
Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
April 26, 2023
Tags
Policy
Epidemics
Politics
From
CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
April 25, 2023
Tags
Biotech and Pharmaceuticals
Business
Eli Lilly and Co
From
CNBC.com News
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
April 25, 2023
Tags
Biotechnology
US: News
Biotech and Pharmaceuticals
From
CNBC.com News
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
April 06, 2023
Tags
Pharmaceuticals
Health care industry
Biogen Inc
From
CNBC.com News
Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
April 05, 2023
Tags
Health & Science
Health care industry
Biogen Inc
From
CNBC.com News
FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease
March 22, 2023
Tags
Breaking News: Business
Biotech and Pharmaceuticals
Breaking news
From
CNBC.com News
FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease
March 20, 2023
Tags
Biotech and Pharmaceuticals
Business
Biotechnology
From
CNBC.com News
Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
March 13, 2023
Tags
US Economy
Eisai Co Ltd
Biotech and Pharmaceuticals
From
CNBC.com News
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
March 06, 2023
Tags
Health care industry
Biogen Inc
Health & Science
From
CNBC.com News
Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
February 23, 2023
Tags
Breaking News: Business
Epidemics
Policy
From
CNBC.com News
Stocks making the biggest moves midday: Deere, Airbnb, AutoNation, Moderna and more
February 17, 2023
Tags
Market Insider
Biogen Inc
Zebra Technologies Corp
From
CNBC.com News
Senators call on Medicare to offer broad coverage of Alzheimer's treatments as public pressure grows
February 17, 2023
Tags
Biogen Inc
Health care industry
Coronavirus
From
CNBC.com News
Maker of promising Alzheimer's drug Leqembi expects full FDA approval this summer, expanded Medicare coverage
February 17, 2023
Tags
U/S/ Economy
Business News
US: News
From
CNBC.com News
Stocks making the biggest moves premarket: Kraft Heinz, Paramount, Airbnb, Tripadvisor and more
February 15, 2023
Tags
stocks
Tripadvisor Inc
Breaking News: Markets
From
CNBC.com News
FDA approves Alzheimer's drug that slowed cognitive decline in clinical trial
January 06, 2023
Tags
Pandemics
US Economy
Eisai Co Ltd
From
CNBC.com News
Stocks making the biggest moves midday: Mission Produce, Nutanix, Alphabet, Tesla and more
December 23, 2022
Tags
Marathon Oil Corp
Carnival Corp
Breaking News: Markets
From
CNBC.com News
Stocks making the biggest moves premarket: Tesla, Nutanix, Meta and more
December 23, 2022
Tags
Meta Platforms Inc
Finance
Tesla Inc
From
CNBC.com News
Stocks making the biggest moves midday: CrowdStrike, Horizon Therapeutics, Petco and more
November 30, 2022
Tags
State Street Corp
DoorDash Inc
Hormel Foods Corp
From
CNBC.com News
Stocks making the biggest moves premarket: Hormel, Petco, CrowdStrike and more
November 30, 2022
Tags
NetApp Inc
Workday Inc
Economy
From
CNBC.com News
Stocks making the biggest moves midday: Apple, DraftKings, Biogen, Williams-Sonoma and more
November 28, 2022
Tags
Taboola
Market Insider
Exxon Mobil Corp
From
CNBC.com News
Stocks making the biggest moves in the premarket: Apple, Taboola, Biogen and more
November 28, 2022
Tags
Wall Street
Investing
Apple Inc
From
CNBC.com News
Stocks making the biggest moves midday: Oatly, Amazon, Hasbro and more
November 14, 2022
Tags
JD/Com Inc
Hasbro Inc
Oatly Group AB
From
CNBC.com News
Stocks making the biggest moves in the premarket: Hasbro, Oatly, Advanced Micro Devices and more
November 14, 2022
Tags
Amazon/com Inc
Virgin Galactic Holdings Inc
Oatly Group AB
From
CNBC.com News
Stocks making the biggest moves midday: Harley-Davidson, Visa, Microsoft, Biogen and more
October 26, 2022
Tags
Chipotle Mexican Grill Inc
Carnival Corp
Finance
From
CNBC.com News
Stocks making the biggest moves midday: Digital World, Domino's, Revlon, Albertsons and more
October 13, 2022
Tags
DISH Network Corp
Colgate/Palmolive Co
Kroger Co
From
CNBC.com News
Jim Cramer goes over the best and worst Q3 performers in the S&P 500
October 11, 2022
Tags
stocks
VF Corp
Investment Strategy
From
CNBC.com News
Stocks making the biggest moves midday: Apple, Netflix, Biogen, Canopy Growth and more
September 28, 2022
Tags
Breaking News: Markets
Canopy Growth Corp
Stock markets
From
CNBC.com News
Stocks making the biggest moves premarket: Biogen, Thor Industries, Lyft and more
September 28, 2022
Tags
BlackBerry
stocks
Thor Industries Inc
From
CNBC.com News
Biogen to pay $900 million to settle allegations it paid doctors kickbacks to prescribe multiple sclerosis drugs
September 26, 2022
Tags
U/S/ Economy
Biotechnology
Disease outbreaks
From
CNBC.com News
Stocks making the biggest moves midday: Netflix, Las Vegas Sands, Bath & Body Works and more
July 20, 2022
Tags
Markets
Stock markets
Breaking News: Markets
From
CNBC.com News
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.